Checkmate Pharmaceuticals Inc Shares Near 52-Week Low - Market Mover

The shares closed 1.6% above its 52-week low of $2.54, with trading volume lower than its 30 day average

Jan 09, 2022 by Kwhen Finance Editors

Checkmate Pharmaceuticals Inc Shares Near 52-Week Low - Market Mover
Checkmate Pharmaceuticals Inc (CMPI) shares closed today at 1.6% above its 52 week low of $2.54, giving the company a market cap of $55M. The stock is currently down 10.1% year-to-date, down 83.0% over the past 12 months, and down 81.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.

Trading Activity

  • Trading volume this week was 76.6% lower than the 20-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed above its Bollinger band, indicating it may be overbought.

Market Comparative Performance

  • The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Checkmate Pharmaceuticals Inc-1.5-10.1-83.0-85.42.4
Dow Jones Industrial Average-0.0-0.318.7-2.023.2
S&P 500 Index-0.4-1.924.6-2.528.8
Technology Industry3.014.6-63.2-66.517.5

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by 535.2%
  • The company's stock price performance over the past 12 months lags the peer average by 169.4%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Checkmate Pharmaceuticals IncCMPI0-10.1-83.0-85.42.4
Peer AvgN/A0-1.6-30.8-32.326.7
ORIC Pharmaceuticals IncORIC0-2.5-56.3-63.527.7
Otonomy IncOTIC0-3.8-67.0-65.578.9

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: